← Evidence map

ArticleAntimicrobial agents and chemotherapy1995

In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis.

T Hirata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

1995

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

this papertrialcites it

In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis. | OpenQuestion